Why Asia? Q and A with Julien de Salaberry of Galen Growth
Julien de Salaberry is the CEO and founder of Galen Growth Asia (GGA) headquartered in Singapore. This thought leader and digital-health advocate calls himself a “healthcare change catalyst and evangelist who challenges the status quo in healthcare whilst understanding the world in which healthcare providers and organizations function.” With over 15 years of experience in healthcare with leading brands including Eli Lilly, Boston Scientific, Baxter, GSK, and Merck & Co., Julien has a deep understanding of organic and inorganic growth in healthcare in both developed and emerging markets. He has extensive experience all over Europe, the Middle East, and Asia in venture investments and startup advisory environments.
He has created a fund for research and innovation collaboration with cancer as the focus, and now leads GGA, research, analytics, advisory firm (and serious collaboration builder) dedicated to transforming the standard of healthcare in Asia Pacific (AP) through nurturing innovation.
I asked Julien to respond to some questions relevant to GGA’s role to help determine the value of HealthTech and get his perspective on where startups are making a difference. But, first, I felt it key to ask the man passionate about disrupting and improving the HealthTech landscape (and, who clearly isn’t a native to Singapore), why Asia? Insightful responses follow.
Health Tech Game Changers
One To Watch: Tim Fitzpatrick (Health Tech)
1st March 2019Game Changer Kim Webber (Health Tech)
28th February 2019Game Changer Monica Trujillo (Health Tech)
28th February 2019Game Changer Berne Gibbons (Health Tech)
25th February 2019
Yan Chow
Yan Chow Medical Director, Digital Medicine, Translational Medicine, Amgen, US

Jacques Kpodonu
Faculty, Harvard Medical School and Cardiac Surgeon, Beth Israel Deaconess Med Center, US
Digital
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque pretium.
Marketing
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque pretium.
12th EDITION MARCH/APRIL 2019
THE REAL VALUE OF HEALTH TECH
INDEX
Why Asia? Q & A with Julien de Salaberry of Galen Growth
Game Changers:
Jonathan Sudharta, CEO and Co-Founder, Halodoc, Greater Jakarta Area
Dr. Kim Webber, Principal Consultant, Health Strategy Consulting, Australia
Berne Gibbons, Digital Healthcare Consultant/Speaker/Executive Search, Australia
Debra A. Tauber, MSN, RN, CEN, CHSE, Founder/CEO Innovative SimSolutions, LLC, US
Elizabeth Chee, Healthtech Entrepreneur and Consultant, Switzerland
Henrik L. Ibsen, CEO, OpenTeleHealth, Aps, Denmark
Rachel De Sain, Founder/CEO, Codesain, Australia
One to Watch:
Tim Fitzpatrick, Co-Founder and CEO, IKONA Health, US
Stakeholders Series: The Real Value of Health Tech
Yan Chow, Medical Director, Digital Medicine, Translational Medicine, Amgen, US
Features:
Finding the SwitchPoints: Events that Spark Connections
This 15-year-old is Headed to Johns Hopkins
NEXT EDITION: MAY/JUNE Introducer Success Stories
Some of what’s been happening with our game changers who are also members of The Introducer’s companion network, The Frontrunners League:
- From the Women Leaders in Blockchain issue (Jan/Feb edition) – these game changers have self-organized and others have joined on. Monthly networking calls, collaborations, in-person meetings, a think tank in the works, and more.
- Two game changers have connected with an investor for a potential life-changing project regarding the reform of education in an entire country.
- Two game changers have met to formulate a collaboration that would put one game changer’s products in a targeted continent
More to come next edition.